Financial research concept

Patient Enrollment: Clinical Trial Recruitment Progress

Patient enrollment measures how many participants a clinical study plans to recruit or has actually enrolled, making it a key timing input for trial completion and readouts.

By Lee BaileyPublished Sep 21, 2026
Research context

See what supports this page, how current it is, and where comparable or historical context is available.

Research date
Sep 21, 2026Use the dated article and cited sources for the definition, examples, and stated limitations.
Operating-model context
16 connected conceptsPart of the reviewed Biopharma Development and Commercialization; issuer definitions remain distinct where disclosed.

Patient enrollment measures the number of participants targeted or actually enrolled in a clinical study.

ClinicalTrials.gov defines enrollment as the estimated target number or actual total number of participants enrolled. Screening alone does not necessarily count as enrollment.

Why enrollment matters

Enrollment pace can affect:

  • trial completion timing;
  • data-readout timing;
  • clinical spending;
  • competitive positioning; and
  • the risk of protocol changes.

A sponsor can have a scientifically promising study but still face delays if recruitment is slower than expected.

Investor interpretation

Look for:

  • target enrollment;
  • actual enrollment;
  • number of active sites;
  • geographic expansion;
  • inclusion and exclusion criteria;
  • disease prevalence; and
  • competing trials recruiting the same patients.

Source:

Enrollment is a trial-execution measure, not evidence that the treatment is effective.

Part of the Biopharma Development and Commercialization

Connect clinical-trial evidence, FDA application and expedited pathways, collaboration economics, gross-to-net commercialization, and loss-of-exclusivity risk to understand drug-development businesses.

Browse the full operating model in Company Analysis →
Where this concept fits

See It in Company Research

Explore other companies in this operating model

These companies are linked to at least two other reviewed concepts in the same operating model, but are not currently linked to this concept. This is broader research navigation, not evidence that the company reports an equivalent metric.

Continue Research

Continue from the concept into the Grizzly Bulls research surface that best matches the next question. These links are research continuations, not recommendations or required steps.

Compare stocks

Compare biopharma stocks

Continue into stock comparison for pipeline stage, regulatory milestones, commercialization economics, concentration, and valuation context.

Explore more topics in the Financial Research Encyclopedia.